Professor, Oncology, Mayo Medical School
Oncology
Dr. Edward T. Creagan, MD
|
|
Give Review
Dr. Edward T. Creagan is an expert in the field of Oncology. He went to medical school at New York Medical College. Edward T. Creagan, MD is also a published physician. He has 12 paper published. The most recent paper is: Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675. Edward Creagan accepts all Medicare patients.
Publications
- Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675.
- Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
- Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a Melanoma peptide vaccine.
- A dose-escalation study of aerosolized sargramostim in the treatment of metastatic Melanoma: an NCCTG Study.
- A phase II study of ABT-510 (thrombospondin-1 Analog) for the treatment of metastatic melanoma.
- Peptide vaccination of patients with metastatic Melanoma: improved clinical outcome in patients demonstrating effective immunization.
- Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic Melanoma.
- Burnout and balance: how to go the distance in the 21st century.
- Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant Melanoma.
- Phase II trial of KW2189 in patients with advanced malignant Melanoma.
- Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the...
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
University of Michigan Hospitals and Health Centers -
New York Medical College
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1518945054 | |
| NPPES Provider LastName | CREAGAN | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 223.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518945054 |
| Last Name Of The Provider | CREAGAN |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Keith C. Bible, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Harry H. Yoon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charles Erlichman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brian A. Costello, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Paul Haluska Jr., MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sani H. Kizilbash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Pisansky, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lynn C. Hartmann, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Shakila P. Khan, MD |
|
|
Dr. Evanthia Galanis, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|